Učitavanje...
Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors
Background: Most patients with advanced gastrointestinal stromal tumors (GIST) develop drug resistance to tyrosine kinase inhibitors (TKIs) within two years of starting therapy, whereas most chronic myeloid leukemia (CML) patients in chronic phase still exhibit disease control after a decade on ther...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
F1000Research
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3892920/ https://ncbi.nlm.nih.gov/pubmed/24555070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.2-152.v1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|